Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) reached a new 52-week high during trading on Thursday . The stock traded as high as $11.47 and last traded at $11.00, with a volume of 650688 shares. The stock had previously closed at $10.50.
Cybin Trading Up 4.8 %
The stock has a market capitalization of $1.63 billion and a P/E ratio of -43.75. The stock’s fifty day moving average price is $7.87 and its two-hundred day moving average price is $2.95.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
See Also
- Five stocks we like better than Cybin
- How to Invest in Small Cap Stocks
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Consumer Staples Stocks, Explained
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What is a buyback in stocks? A comprehensive guide for investors
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
